posted May 15, 2008 04:26 PM
http://www.pr-inside.com/evolving-treatments-for-copd-emphasizing-innovativ-r591625.htm
(Nashua, NH) - In terms of patient morbidity, chronic pulmonary obstructive disease (COPD) rivals congestive heart failure as a major healthcare challenge. Primarily smoking-related, COPD is a progressive disorder of the lungs characterized by airflow obstruction. It is an umbrella term used to define diseases that cause airflow obstruction, such as chronic bronchitis, emphysema or combinations of both. Worldwide estimates
for COPD reach as high as 600 million people. The World Health Organization predicts that by 2020 it will be the third leading cause of death in the world. Therapies which address the underlying tissue damage in COPD and prevent the progressive decline in lung function which is a hallmark of this disease are considered the path to improved patient quality-of-life. With this in mind, a number of companies are taking a fresh look at COPD therapeutics, developing new and novel approaches to this family of diseases. By targeting new disease mechanisms and focusing on the underlying pathologies causing COPD, these sector participants are attempting to move beyond the palliative treatments that have historically formed the standard of care for COPD patients. Drug candidates currently in development include enzyme and synthesis inhibitors, chemokine antagonists and receptor agonists. Interventional approaches include drug-eluting bronchial stents and minimally invasive devices.
These findings are part of a comprehensive report that examines the potential of development-stage treatments and therapies for COPD.
More information is also available at www.applieddata.org .
About Applied Data
Applied Data Research is a healthcare therapeutics consulting firm focused on medical market strategies, product commercialization, venture development, and market research. We assist medical market participants in achieving their business objectives through the creation of detailed business development strategies, product commercialization programs, and comprehensive market and technology research and analysis. We deliver our knowledge franchise through concise market appraisals, company analysis, and technology reports. Our publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge necessary to refine and execute their marketing plans and achieve their financial targets.
Contact:
Greg Stone
Voice: 603-595-6225 www.applieddata.org
Source: Applied Data Research
Lindaland
UBBFriend: Email This Page to Someone! 
posted May 15, 2008 04:26 PM